Miraghajani Maryam, Dehsoukhteh Somayeh Shahraki, Rafie Nahid, Hamedani Sahar Golpour, Sabihi Sima, Ghiasvand Reza
PhD. Doctoral Student, Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
MSc. Coach, Department of Statistics, Faculty of Sciences, Zabol University, Zabol, Iran.
Sao Paulo Med J. 2017 Mar-Apr;135(2):169-178. doi: 10.1590/1516-3180.2016.0311271216.
: Some studies have suggested a wide range of possible mechanisms through which probiotics may play a role in diabetes prevention and treatment. However, the underlying mechanisms are not fully understood. We conducted this study to review the potential mechanisms suggested for the effect of probiotics in diabetes.
: Narrative review conducted at the Food Security Research Center of Isfahan.
: A search in the electronic databases MEDLINE (PubMed), Cochrane Library, Web of Science and Google scholar was performed up to October 2016.
: The initial search yielded 1214 reports. After removing duplicates, 704 titles and abstracts were screened. Finally, out of 83 full-text articles that were reviewed for eligibility, 30 articles were included in the final analysis. The anti-diabetic mechanisms for probiotics reported encompass intraluminal and direct effects on the intestinal mucosa and microbiota (n = 13), anti-inflammatory and immunomodulatory effects (n = 10), antioxidative effects (n = 5), effects on endoplasmic reticulum (ER) stress and expression of genes involved in glucose homeostasis and insulin resistance (n = 6), with some studies pointing to more than one mechanism.
: The results may throw some light on the capacity of probiotics as a novel approach towards controlling diabetes. However, further human studies are warranted to elucidate and confirm the potential role of probiotics in diabetes prevention and treatment. Also, it needs to be ascertained whether the effectiveness of probiotics in diabetes prevention and treatment is dependent on the strain of the microorganisms.
一些研究提出了多种可能的机制,通过这些机制益生菌可能在糖尿病的预防和治疗中发挥作用。然而,其潜在机制尚未完全明确。我们开展本研究以综述关于益生菌对糖尿病影响的潜在机制。
在伊斯法罕食品安全研究中心进行的叙述性综述。
截至2016年10月,在电子数据库MEDLINE(PubMed)、Cochrane图书馆、科学引文索引和谷歌学术中进行检索。
初步检索得到1214篇报告。去除重复项后,筛选了704篇标题和摘要。最后,在83篇经资格审查的全文文章中,30篇文章纳入最终分析。报告的益生菌抗糖尿病机制包括对肠腔以及对肠黏膜和微生物群的直接作用(n = 13)、抗炎和免疫调节作用(n = 10)、抗氧化作用(n = 5)、对内质网(ER)应激以及对参与葡萄糖稳态和胰岛素抵抗的基因表达的影响(n = 6),一些研究指出存在不止一种机制。
这些结果可能有助于了解益生菌作为控制糖尿病新方法的能力。然而,需要进一步开展人体研究以阐明并确认益生菌在糖尿病预防和治疗中的潜在作用。此外,还需确定益生菌在糖尿病预防和治疗中的有效性是否取决于微生物菌株。